These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21819452)

  • 41. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
    Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
    J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproducible measurements to quantify cutaneous involvement in scleroderma.
    Aghassi D; Monoson T; Braverman I
    Arch Dermatol; 1995 Oct; 131(10):1160-6. PubMed ID: 7574833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma.
    Makino K; Jinnin M; Hirano A; Yamane K; Eto M; Kusano T; Honda N; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
    J Immunol; 2013 Apr; 190(8):3905-15. PubMed ID: 23509348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin involvement in systemic sclerosis.
    Czirják L; Foeldvari I; Müller-Ladner U
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v44-5. PubMed ID: 18784142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
    Varga J; Abraham D
    J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.
    Beyer C; Huscher D; Ramming A; Bergmann C; Avouac J; Guiducci S; Meier F; Vettori S; Siegert E; Jaeger VK; Maurer B; Riemekasten G; Walker U; Müller-Ladner U; Valentini G; Matucci-Cerinic M; Allanore Y; Distler O; Schett G; Distler JHW
    Ann Rheum Dis; 2018 Apr; 77(4):626-628. PubMed ID: 28495672
    [No Abstract]   [Full Text] [Related]  

  • 47. Tyrosine kinases in the pathogenesis of tissue fibrosis in systemic sclerosis and potential therapeutic role of their inhibition.
    Mendoza FA; Piera-Velazquez S; Jimenez SA
    Transl Res; 2021 May; 231():139-158. PubMed ID: 33422651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scleroderma - new aspects in pathogenesis and treatment.
    Balbir-Gurman A; Braun-Moscovici Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):13-24. PubMed ID: 22424190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging targeted therapies in scleroderma lung and skin fibrosis.
    Maurer B; Distler O
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):843-58. PubMed ID: 22265265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.
    Chairta P; Nicolaou P; Sokratous K; Galant C; Houssiau F; Oulas A; Spyrou GM; Alarcon-Riquelme ME; Lauwerys BR; Christodoulou K
    Arthritis Res Ther; 2020 May; 22(1):107. PubMed ID: 32381114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasound imaging accurately detects skin thickening in a mouse scleroderma model.
    Tedstone JL; Richards SM; Garman RD; Ruzek MC
    Ultrasound Med Biol; 2008 Aug; 34(8):1239-47. PubMed ID: 18359143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging Roles of Matricellular Proteins in Systemic Sclerosis.
    Feng D; Gerarduzzi C
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flow cytometric identification of fibrocytes in scleroderma lung disease.
    Russell TM; Herzog EL; Bucala R
    Methods Mol Biol; 2012; 900():327-46. PubMed ID: 22933077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.
    Kania G; Rudnik M; Distler O
    Nat Rev Rheumatol; 2019 May; 15(5):288-302. PubMed ID: 30953037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging biomarkers in systemic sclerosis.
    Manetti M
    Curr Opin Rheumatol; 2016 Nov; 28(6):606-12. PubMed ID: 27380110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic sclerosis.
    Allanore Y; Simms R; Distler O; Trojanowska M; Pope J; Denton CP; Varga J
    Nat Rev Dis Primers; 2015 Apr; 1():15002. PubMed ID: 27189141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A modified scleroderma skin scoring method.
    Kahaleh MB; Sultany GL; Smith EA; Huffstutter JE; Loadholt CB; LeRoy EC
    Clin Exp Rheumatol; 1986; 4(4):367-9. PubMed ID: 3791722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New potential biomarkers for disease activity and fibrosis in systemic sclerosis.
    Vadasz Z; Rimar D
    Isr Med Assoc J; 2014 Oct; 16(10):629-30. PubMed ID: 25438451
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitating skin fibrosis: innovative strategies and their clinical implications.
    Abignano G; Del Galdo F
    Curr Rheumatol Rep; 2014 Mar; 16(3):404. PubMed ID: 24442715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of a durometer to assess skin hardness.
    Falanga V; Bucalo B
    J Am Acad Dermatol; 1993 Jul; 29(1):47-51. PubMed ID: 8315077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.